Sign Up Today and Learn More About Molekule Stock
Invest in or calculate the value of your shares in Molekule or other pre-IPO companies through EquityZen's platform.
Molekule Stock (MOLE)
Clean Air Company
Molekule is an air purifier startup.
About Molekule Stock
Founded
2014
Headquarters
San Francisco, CA, US
Total Funding
140M
Industries
Software, Artificial Intelligence, Data and Analytics
Molekule is an air purifier startup whose mission is to deliver clean air to everyone, everywhere. Molekule is powered by the purification technology called PECO (Photo Electrochemical Oxidation) which works at the molecular level to destroy pollutants including VOCs, mold, bacteria, viruses, and allergens. Molekule's range of air purification solutions have been tested by third-party laboratories, as well as continual internal testing, and its medical-grade products have been granted medical device clearance by the FDA.
Molekule was founded in 2014 by Dilip Goswami, Dr. Yogi Goswami, and Jaya Rao and is headquartered in San Francisco, California. Notable investors include Kevin Love, RPS Ventures, and Uncork Capital.
Molekule Press Mentions
Stay in the know about the latest news on Molekule
Innovative Molekule Air Purifiers Now Available at Crate & Barrel
prnewswire • Nov 12, 2024
Amazon Prime Day deal: Molekule offers unprecedented 40% discount on PECO-HEPA air purifiers
finance • Aug 03, 2024
Prime Day deal cuts this Molekule air purifier to its lowest price – but be quick!
t3 • Aug 03, 2024
Breathe Easier This Prime Day With 40% Off Molekule Air Purifiers
cnet • Aug 03, 2024
Molekule, Inc. secures patent for revolutionary coating removal technology funded by DOD’s SERDP agency
globenewswire • Aug 03, 2024
Investors in Molekule
Discover investors in Molekule stock and explore their portfolio companies
Molekule Management
Leadership team at Molekule
Chief Executive Officer
Jonathan Harris
Chief Financial Officer
Rajesh Sharma
Join now and verify your accreditation status to gain access to:
- Molekule current valuation
- Molekule stock price
- Available deals in Molekule and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Molekule stock?
Accredited investors can buy pre-IPO stock in companies like Molekule through EquityZen funds. These investments are made available by existing Molekule shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Molekule stock?
Shareholders can sell their Molekule stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
